A
utologous fat transfer has received well-deserved acceptance for a wide variety of clinical applications over the past decade. Opinions vary regarding optimal techniques for harvesting and decanting particulate fat. One consistent clinical observation and a simple change of technique may help improve fat grafting outcomes.
Approximately 20 years ago, the senior author tried adding several drops of heparin solution (5,000 u/mL) to each 35 cc harvest syringe and each 10 cc decanting syringe in a successful attempt to prevent fibrin plug formation, easing transfer of particles through small-bore cannulas (1.2-1.5 mm). Use of heparin also reduced fibrin formation in our protocol for nonliposuction mechanical morcellation of adipose. 1 Over the years, we realized that tissue separation using our heparin-enhanced gravitational protocol has been consistent and relatively rapid, without the concerns voiced by other surgeons about inadequate, inconsistent, and/or slow separation often seen with traditional gravitational decanting methods.
Recently, when several graft syringes failed to properly decant on the back table, we realized that those specific syringes had not been heparinized before harvest. A subsequent trial of otherwise mirror-identical harvests ( Fig. 1) showed a dramatic difference in the efficacy of gravitational decanting between heparinized and nonheparinized syringes (Fig. 2) . Ease of flow of the graft through a 1.5-mm cannula was also subjectively better in the syringe that had been heparin-primed. We hypothesize that both fibrin formation and cross-linking inside the decanting syringes are minimized with the addition of heparin, lessening or obviating the need for centrifugal force to separate liquids from solids. It is our experience that the lowered viscosity also eases flow during subsequent transfer (perhaps by lowering the plunger pressures needed) and likely enhances the ultimate uniformity of graft distribution.
Biologically, there is some evidence to suggest that heparinoids may also serve to protect native Fibroblast Growth Factor-2 in fat grafts from acid-and heat-inactivation, and from protease degradation. 2 Because Fibroblast Growth Factor-2 is believed to stimulate the proliferation and differentiation of adipose precursor cells, low doses of exogenous heparin might enhance early revascularization and ultimately improve fat graft survival. 2 We have seen no increase of ecchymoses or a single hematoma or seroma in the recipient sites for heparintreated fat grafts in any of several thousand consecutive cases. Importantly, there have also been no deep vein thrombosis or pulmonary emboli in these same patients, who did not otherwise receive subcutaneous heparin or other anticoagulant during the postoperative period.
We suggest that formal quantification of heparin's effects on particulate adipose grafts could help further refine autologous fat transfer techniques and may also improve fat graft survival. 
